ashgan osman (9 resultados)

Condición: New.

Taschenbuch. Condición: Neu. ABO and genetic risk factors associated with venous thrombosis | ABO, factor V-Leiden and FVIII are a risk factors associated with venous thrombosis | Ashgan Osman (u. a.) | Taschenbuch | 92 S. | Englisch | 2014 | Scholars' Press | EAN 9783639664843 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

paperback. Condición: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In Sudan, Vein Thromboembolism (DVT/PE) increases the rate of morbidity and mortality among young individuals. While the impact of the acquired risk factors in VTE are well established, information's about influencing of hereditary risk factors ( genetic mutations) in VTE and translation of this risk information's to clinical practices are still need to be clarify. This book therefore, aimed to identify the most common hereditary & acquired risk factors associated with VTE and to correlate the finding with the clinical applications of thrombophilia screening tests. Our finding in this book showed that, hereditary risk factors particularly, factor V-Leiden, factor II G20210A mutations, non-O blood group, elevated concentrations of factors VIII and von Willebrand proteins were the most important risk factors for VTE among Sudanese patients. The results showed that, these findings should change the therapeutic policy into lifelong prophylactic therapy in patients with genetics risk factors and individual with high level of Factor VIII. Initial workup for thrombophilia should include these factor but not Prothrombin II G20210A gene mutation. 92 pp. Englisch.

Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Osman AshganAshgan Abd Elhalim Osman Ahmed. Graduated at Faculty of medical laboratory sciences (Hematology and blood transfusion) Omdurman Ahlia University, Sudan. Awarded M.Sc in Hematology, University of Juba. Awarded PhD in molec.

Condición: New. Print on Demand.

Condición: New. PRINT ON DEMAND.

Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -In Sudan, Vein Thromboembolism (DVT/PE) increases the rate of morbidity and mortality among young individuals. While the impact of the acquired risk factors in VTE are well established, information's about influencing of hereditary risk factors ( genetic mutations) in VTE and translation of this risk information's to clinical practices are still need to be clarify. This book therefore, aimed to identify the most common hereditary & acquired risk factors associated with VTE and to correlate the finding with the clinical applications of thrombophilia screening tests. Our finding in this book showed that, hereditary risk factors particularly, factor V-Leiden, factor II G20210A mutations, non-O blood group, elevated concentrations of factors VIII and von Willebrand proteins were the most important risk factors for VTE among Sudanese patients. The results showed that, these findings should change the therapeutic policy into lifelong prophylactic therapy in patients with genetics risk factors and individual with high level of Factor VIII. Initial workup for thrombophilia should include these factor but not Prothrombin II G20210A gene mutation.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 92 pp. Englisch.

Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In Sudan, Vein Thromboembolism (DVT/PE) increases the rate of morbidity and mortality among young individuals. While the impact of the acquired risk factors in VTE are well established, information's about influencing of hereditary risk factors ( genetic mutations) in VTE and translation of this risk information's to clinical practices are still need to be clarify. This book therefore, aimed to identify the most common hereditary & acquired risk factors associated with VTE and to correlate the finding with the clinical applications of thrombophilia screening tests. Our finding in this book showed that, hereditary risk factors particularly, factor V-Leiden, factor II G20210A mutations, non-O blood group, elevated concentrations of factors VIII and von Willebrand proteins were the most important risk factors for VTE among Sudanese patients. The results showed that, these findings should change the therapeutic policy into lifelong prophylactic therapy in patients with genetics risk factors and individual with high level of Factor VIII. Initial workup for thrombophilia should include these factor but not Prothrombin II G20210A gene mutation.